Accessbio

About:

Access BIO is a consulting group focused on the development of drug, biologic, and medical device products.

Top Investors: Global Health Investment Fund (GHIF)

Description:

Access BIO is a consulting group focused on the development of drug, biologic, and medical device products. The company’s product portfolio includes rapid diagnostic tests, molecular diagnostics, biosensors, and more. Access BIO was founded in 2001 and is based in Somerset, New Jersey.

Total Funding Amount:

$20M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Somerset, New Jersey, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)accessbio.net

Founders:

Young Ho Choi

Number of Employees:

1-10

Last Funding Date:

2016-04-06

IPO Status:

Public

Industries: